Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-19

Clinical Trial Update: Naturlose (D-Tagatose) Efficacy Evaluation Trial [Phase 3]

View source ↗

Summary

Phase 3 efficacy evaluation trial for Naturlose (D-tagatose) in type 2 diabetes has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naturlose (D-tagatose)

Snippet

Sponsor: Robert Lodder | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2014-11-19